CHARGED ALPHA
Stock Analysis
Stock Library / ADBE
ADBE Unclassified Latest YouTube: Q2 FY2026

ADBE

Live stock metrics, chart context, a quarter-by-quarter episode archive, and a deeper competitor comparison so this page behaves more like an investor workspace than a flat episode link page.

Latest earnings video

ADBE Stock: Record Quarter, Raised Guide, Stock Dumps 11% Q2 FY2026

Library coverage

Episodes tracked
5
Episodes linked
4
Latest video
Q2 FY2026
Podcast available
Yes
Current price
$249.09
+11.28 (+4.74%)
Trailing / Forward P/E
14.26x
Forward: 9.06x
Market cap / Volume
Volume:
Revenue / Earnings Growth
12.7%
Earnings: 7.9%
Margins
35.3% op
Gross: 89.4% · Net: 28.7%
Balance sheet
0.75x current
Debt / Equity: 61.4
52-week range / Beta
$190.12 - $376.16
Beta: 1.43
Analyst target
$269.61
Upside: 8.2%
Cash / shareholder return
9.31% FCF yield
Dividend yield: —

Company context

Industry: Software - Application
Country: United States
Employees:
Price to book: 8.63x
Return on equity: 63.0%
Adobe Inc. operates as a technology company worldwide. The Digital Media segment offers products and services that enable individuals, teams, and enterprises to create, publish, and promote content. This segment serves photographers, video editors, graphic and experience designers, game developers, content creators, students, marketers, business owners, knowledge workers, and consumers. The Digital Experience segment provides an integrated platform; and products, services, and solutions that enable brands and businesses to create, manage, execute, measure, monetize, and optimize customer experiences from analytics to commerce. This segment serves marketers, advertisers, agencies, publishers, merchandisers, merchants, web analysts, data scientists, developers, and executives across the C-suite. The Publishing and Advertising segment offers e-learning, technical document publishing, web conferencing, document and forms platform, web application development, printing, and Adobe Advertising solutions. It also provides consulting, training, customer management, technical support, and learning services. The company offers its solutions to enterprise customers, and businesses and consumers; and licenses its products to end-user customers through app stores and website at adobe.com. It markets and distributes its products through distributors, retailers, software developers, mobile app stores, systems integrators, independent software vendors, value-added resellers, and original equipment and hardware manufacturers. The company also provides an online visibility management and content marketing software-as-a-service platform. The company has a strategic alliance with HUMAIN for the development of generative AI models and AI-powered applications. The company was formerly known as Adobe Systems Incorporated and changed its name to Adobe Inc. in October 2018. Adobe Inc. was founded in 1982 and is headquartered in San Jose, California.

Price chart

Market context for ADBE

Competitive view

ADBE vs. two close competitors

This section compares the current company against two nearby peers on valuation, growth, margins, balance-sheet strength, and investment setup. Green generally marks the strongest relative figure for that row, while red marks the weakest.

ADBE latest YouTube video thumbnail YouTube
ADBE
ADBE
Latest video
Q2 FY2026
Growth is positive but not explosive, which usually supports a steadier compounding case than a hyper-growth story.
Profitability is a real strength here, with healthy operating margins helping support resilience through weaker cycles.
Valuation looks more grounded than many growth names, which can improve the risk/reward if fundamentals hold up.
Risk profile looks relatively manageable compared with many peers, especially if operating execution remains stable.
Danaher Corporation latest YouTube video thumbnail YouTube
Danaher Corporation
DHR
Latest video
Q2 2026
Growth profile looks strong right now, with above-average top-line and/or earnings momentum.
Cash generation stands out versus market value, which helps the stock absorb valuation pressure better than weaker cash converters.
Valuation sits in a middle zone where future upside likely depends more on quarterly execution than on multiple re-rating alone.
Risk profile looks relatively manageable compared with many peers, especially if operating execution remains stable.
West Pharmaceutical Services Inc. latest YouTube video thumbnail YouTube
West Pharmaceutical Services Inc.
WST
Latest video
Q2 2026
Growth is positive but not explosive, which usually supports a steadier compounding case than a hyper-growth story.
Profitability is serviceable, but it does not obviously dominate peers on margin or cash conversion alone.
Valuation already asks investors to pay up, so the upside case depends on continued execution staying strong.
Risk profile looks relatively manageable compared with many peers, especially if operating execution remains stable.
Market Cap
More scale can mean deeper resources and resilience, although bigger does not automatically mean better upside.
ADBE
$99.01B
ADBE
DHR
$141.00B
Danaher Corporation
WST
$23.30B
West Pharmaceutical Services Inc.
Trailing P/E
Lower trailing P/E can indicate a cheaper valuation relative to trailing earnings, but it may also reflect slower growth or higher perceived risk.
ADBE
14.3x
ADBE
DHR
35.8x
Danaher Corporation
WST
42.4x
West Pharmaceutical Services Inc.
Forward P/E
Forward P/E is often a better read on what investors are paying for the next year of earnings power.
ADBE
9.1x
ADBE
DHR
21.7x
Danaher Corporation
WST
33.3x
West Pharmaceutical Services Inc.
Revenue Growth
Higher revenue growth usually signals stronger demand, market share gains, or a business still in expansion mode.
ADBE
12.7%
ADBE
DHR
5.5%
Danaher Corporation
WST
13.8%
West Pharmaceutical Services Inc.
Earnings Growth
Faster earnings growth matters because it shows management is converting sales momentum into shareholder value.
ADBE
7.9%
ADBE
DHR
59.7%
Danaher Corporation
WST
18.1%
West Pharmaceutical Services Inc.
Operating Margin
Higher operating margin suggests better operating discipline, pricing power, or a structurally stronger business model.
ADBE
35.3%
ADBE
DHR
19.8%
Danaher Corporation
WST
22.5%
West Pharmaceutical Services Inc.
Gross Margin
Gross margin helps show how much product-level pricing power and unit economics a company has before overhead.
ADBE
89.4%
ADBE
DHR
58.8%
Danaher Corporation
WST
36.8%
West Pharmaceutical Services Inc.
Net Margin
Higher net margin means more of each dollar of revenue reaches the bottom line after all costs.
ADBE
28.7%
ADBE
DHR
15.9%
Danaher Corporation
WST
17.0%
West Pharmaceutical Services Inc.
Return on Equity
ROE shows how efficiently management turns shareholder capital into profits, though leverage can inflate it.
ADBE
63.0%
ADBE
DHR
7.6%
Danaher Corporation
WST
19.1%
West Pharmaceutical Services Inc.
Free Cash Flow Yield
Higher free cash flow yield can indicate a stronger cash return relative to the stock's market value.
ADBE
9.3%
ADBE
DHR
3.1%
Danaher Corporation
WST
1.2%
West Pharmaceutical Services Inc.
Debt to Equity
Lower leverage usually means less balance-sheet risk, though capital-intensive sectors naturally run higher debt loads.
ADBE
61.44x
ADBE
DHR
52.97x
Danaher Corporation
WST
10.59x
West Pharmaceutical Services Inc.
Current Ratio
A stronger current ratio usually signals better short-term liquidity and more room to absorb shocks.
ADBE
0.75x
ADBE
DHR
1.65x
Danaher Corporation
WST
2.82x
West Pharmaceutical Services Inc.
Beta
Lower beta often means lower volatility versus the market, while higher beta usually brings a rougher ride.
ADBE
1.43
ADBE
DHR
0.82
Danaher Corporation
WST
1.16
West Pharmaceutical Services Inc.
Dividend Yield
Dividend yield matters for income-focused investors, but a high yield can also reflect a stressed stock price.
ADBE
ADBE
DHR
0.7%
Danaher Corporation
WST
0.3%
West Pharmaceutical Services Inc.
Analyst Upside
Higher analyst upside suggests the Street still sees room between current price and consensus fair value.
ADBE
8.2%
ADBE
DHR
13.5%
Danaher Corporation
WST
21.7%
West Pharmaceutical Services Inc.

Related research

Non-quarter videos featuring ADBE

Special-topic videos, explainers, and shorts connected to this ticker.

All Research Sections
Shorts and Clips 2026-06-11

ADBE -11% — RECORD QUARTER, -11% ANYWAY #Shorts

A fast Charged Alpha clip pointing viewers into the latest earnings coverage.

Shorts and Clips 2026-06-11

ADBE Stock: Q2 FY2026 in 60 Seconds #Shorts

A fast Charged Alpha clip pointing viewers into the latest earnings coverage.

Episode timeline

Episode archive for ADBE

Each row is one earnings episode with every verified platform link available.

Q2 FY2026
Episode live
Published youtube podcast complete
ADBE Stock: Record Quarter, Raised Guide, Stock Dumps 11% Q2 FY2026
Quarterly earnings-analysis entry for ADBE. Use the links on the right to open the video or podcast episode.
Q1 FY2026
Episode live
Published youtube podcast complete
ADBE Stock: Down 38% From High -- AI Threat or Hidden Value? Q1 FY2026
Quarterly earnings-analysis entry for ADBE. Use the links on the right to open the video or podcast episode.
Q1 FY2026
Episode live
Published youtube complete
ADBE Stock: $6.4B Revenue — Q1 FY2026 Earnings Analysis
Quarterly earnings-analysis entry for ADBE. Use the links on the right to open the video or podcast episode.
Q1 FY2026
Episode live
Published youtube complete
ADBE Stock: $6.4B Revenue — Q1 FY2026 Earnings Analysis
Quarterly earnings-analysis entry for ADBE. Use the links on the right to open the video or podcast episode.
Q1 2026
Episode pending
Pending link pending
ADBE Q1 2026 earnings analysis
Quarterly earnings-analysis entry for ADBE. Use the links on the right to open the video or podcast episode.
No verified episode link yet